Search
Spotlight
ASH 2020 News
Global Oncology News
Neoadjuvant HER2+
CAR-T Cell Therapy Learning Module
Colorectal Cancer
Interactive Tools
Targeted Therapy in Blastic Plasmacytoid Dendritic Cell Neoplasm
Utilizing Tumor Metabolism in Solid Malignancies
Specialty
Biosimilars
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
News
Media
Insights
Medical World News
News Network
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
OncLive Events Scientific Interchange Workshop Series
PER Events
State of the Science Summit / IPC
Webinars
Publications
Resources
Community
Interactive Tools
Learning Modules
Partners
Pipeline Report
Sponsored
CME
Subscribe
eNewsletter
Search
Spotlight
ASH 2020 News
Global Oncology News
Neoadjuvant HER2+
CAR-T Cell Therapy Learning Module
Colorectal Cancer
Interactive Tools
Targeted Therapy in Blastic Plasmacytoid Dendritic Cell Neoplasm
Utilizing Tumor Metabolism in Solid Malignancies
Specialty
See All >
Biosimilars
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
Rapid Readouts: Momelotinib's Spleen, Symptom, and Anemia Efficacy
December 10, 2020
Srdan Verstovsek, MD, PhD, MD Anderson Cancer Center
Srdan Verstovsek, MD, PhD, MD Anderson Cancer Center
Related Content:
Rapid Readouts
|
Hematologic Oncology
FDA Approves Subcutaneous Daratumumab Plus VCd for Newly Diagnosed Light-Chain Amyloidosis
Dr. Kumar on Understanding the Safety Profiles of Combination Therapies in Multiple Myeloma
Dr. Olin on the Rationale to Evaluate Menin Inhibitors in AML
x